Clinical TrialsSearch results
Number of results: 750
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study)
- Type 2 diabetic nephropathy with hyperlipidemia
- Japanese Society of Kidney and Lipids
- 2006-03-27
Completed
- Effect of tofogliflozin and pioglitazone on hepatic steatosis in NAFLD patients with type 2 diabetes.
- Type 2 Diabetes, NAFLD
- Yoneda Masato
- 2019-02-26
Recruiting
- Long-term comparison of luseogliflozin vs sitagliptin for Type 2 diabetes mellitus patients with NASH/NAFLD
- Type 2 diabetes mellitus with NAFLD/NASH
- Kobayashi Takashi
- 2020-03-03
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- Comparative study on the degree of caloric restriction of diet as a dietary treatment for obese patients with type 2 diabetes: a multi-center prospective, randomized, comparative study
- Type 2 diabetes mellitus
- Graduate School of Medicine, Yokohama City University
- 2009-07-10
Completed
- Investigation of the safety and efficacy of semaglutide s.c. in combination with NNC0480-0389 in participants with type 2 diabetes - a dose finding study(NN9389-4606)
- Type 2 diabetes mellitus
- Oyatani Akihito
- 2021-12-10
Completed
- MARIA19-09T
- type 2 diabetes mellitus
- Nakamura Yuta
- 2020-04-10
Other
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes (AWARD-JPN )
- Type 2 diabetes
- Masaki Takeshi
- 2021-04-06
Other
- Long-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
- Type 2 diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-07